Literature DB >> 21258803

Systemic lupus erythematosus in the elderly.

Achouak Achour1, Amani Mankaï, Yosra Thabet, Wahiba Sakly, Fehmi Braham, Chedia Kechrid, Fethi Bahri, Elyès Bouajina, Sawssen Chouchène, Ons Haddad, Ibtissem Ghedira.   

Abstract

Onset of the disease above the age of 65 years is unusual. This study was undertaken to determine retrospectively the clinical and laboratory features in SLE patients aged over 65 years. It is a retrospective study about 18 elderly patients with SLE out of 342 diagnosed between 1994 and 2009 in the center of Tunisia. All patients had at least 4 of 11 revised ACR criteria of SLE. The frequency of SLE in the elderly was 5.3%. The median age was 70 years (range 66 and 78 years). The sex ratio F/M was 5. The most frequent clinical signs were anemia (83.3%), arthralgia (55.5%), arthritis (38.9%), and malar rash (33.3%). The proteinuria and the neuropsychiatric troubles were present in 27.8% of cases. The pericarditis was present in 16.7% of cases. Antibodies to double stranded DNA (anti-dsDNA) were detected in 66.7%, anti-nucleosome in 50%, anti-SSA and anti-RNP in 27.8%, anti-Sm in 22%, and anti-SSB in 11%. Elderly patients with SLE exhibit distinct clinical and biological manifestations from the classic form. Thus, greater attention should be given for this particular subgroup of SLE patients to avoid delays in diagnosis or misdiagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258803     DOI: 10.1007/s00296-010-1744-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

Review 2.  The role of nucleosomes in lupus.

Authors:  Z Amoura; S Koutouzov; J C Piette
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index.

Authors:  F Formiga; I Moga; M Pac; F Mitjavila; A Rivera; R Pujol
Journal:  Lupus       Date:  1999       Impact factor: 2.911

5.  [Clinical and serological characteristics of systemic lupus erythematosus: 128 cases].

Authors:  I Ghedira; W Sakly; M Jeddi
Journal:  Pathol Biol (Paris)       Date:  2002-02

6.  Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States.

Authors:  R A Kaslow; A T Masi
Journal:  Arthritis Rheum       Date:  1978-05

7.  Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.

Authors:  M H Houman; M Smiti-Khanfir; I Ben Ghorbell; M Miled
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

Review 9.  Systemic lupus erythematosus in the elderly.

Authors:  J Rovenský; A Tuchynová
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

10.  Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.

Authors:  Moez Jallouli; Makram Frigui; Mohamed Ben Hmida; Sameh Marzouk; Neila Kaddour; Zouheir Bahloul
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-11
View more
  4 in total

Review 1.  Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Authors:  Savino Sciascia; Maria Laura Bertolaccini; Dario Roccatello; Munther A Khamashta; Giovanni Sanna
Journal:  J Neurol       Date:  2014-06-21       Impact factor: 4.849

2.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

3.  Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis.

Authors:  Shanshan Wu; Yanhai Wang; Jiaojiao Zhang; Bo Han; Baishan Wang; Wanli Gao; Ning Zhang; Cheng Zhang; Feng Yan; Zhijing Li
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

Review 4.  Update on Biologic Therapies for Systemic Lupus Erythematosus.

Authors:  Helena Hiemisch Lobo Borba; Andreas Funke; Astrid Wiens; Shirley Ramos da Rosa Utiyama; Cássio Marques Perlin; Roberto Pontarolo
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.